Unfortunately, these attempts have yielded limited success. Until now, a limited number of studies have determined the impact of pharmacy-based interventions with regard to GIOP [15, 19]. In the Dutch health care system, pharmacists share a responsibility with prescribers to properly inform selleck screening library patients on the advantages and disadvantages of pharmacotherapy and to assist physicians in this respect. Therefore, pharmacists could play an important role in the implementation of guidelines for management of GIOP. The previously conducted studies that used a pharmacy-based approach for the improvement of GIOP have shown a significant increase in the prescribing rates of prophylactic osteoporosis drugs.

However, these studies were limited by a lack of randomisation [15] and a lack of power [19]. Therefore, the aim of this randomised controlled trial was to determine whether feedback by community pharmacists to physicians of patients eligible for GIOP would stimulate the implementation of the Dutch

GIOP guideline. Materials and methods Study participants and setting This randomised controlled trial was conducted at 29 pharmacies from different parts in the Netherlands. this website Pharmacists were invited to participate in the study by a short announcement in the Dutch Pharmacy Journal. The pharmacies were located all over the Netherlands. There was no particular chain of pharmacies involved. At each participating pharmacy, drug dispensing data from all patients were collected at baseline (date of first data extraction, January 2005 to May 2005). We selected all patients who were dispensed ≥675 mg prednisone equivalents (≥67.5 defined daily dosages [DDDs] [7, 8]) without a concomitant bisphosphonate

prescription within the 180 days before baseline and with at least one prescription for a glucocorticoid within the 90 days before baseline. In the Netherlands, the vast majority of the population obtains their medication from only one community pharmacy, enabling the collection of longitudinal medication histories Interleukin-2 receptor [20]. Medication records of patients were pseudonymised and were sent to the researchers. We have excluded patients who had less than 6 months of medication records before baseline. Intervention Block randomisation (using the survey select procedure of SAS, version 8.2) was performed. After the randomisation, the pharmacists received feedback on patients who were assigned to the intervention group. They received a letter with the Dutch GIOP guideline [8] and a list on paper with all the eligible patients. Pharmacists were expected to forward the patients on this list to their own general practitioners and to suggest the start of osteoporosis prophylaxis (a bisphosphonate). It was left at the disposal of the individual pharmacist how to communicate with the general practitioner.